Loading...
Dernières publications
-
Luce Barbat Du Closel, Nathalie Bonello-Palot, Yann Pereon, Andoni Echaniz-Laguna, Jean Philippe Camdessanche, et al.. Clinical and electrophysiological characteristics of women with X-linked Charcot-Marie-Tooth disease. European Journal of Neurology, 2023, 30 (10), pp.3265-3276. ⟨10.1111/ene.15937⟩. ⟨hal-04254200⟩
-
-
Joe-Elie Salem, Marie Bretagne, Baptiste Abbar, Sarah Leonard-Louis, Stéphane Ederhy, et al.. Abatacept/Ruxolitinib and Screening for Concomitant Respiratory Muscle Failure to Mitigate Fatality of Immune-Checkpoint Inhibitor Myocarditis. Cancer Discovery, 2023, 13 (5), pp.1100-1115. ⟨10.1158/2159-8290.CD-22-1180⟩. ⟨hal-04578810⟩
-
-
Corinna Preuße, Barbara Paesler, Christopher Nelke, Derya Cengiz, Thomas Müntefering, et al.. Skeletal muscle provides the immunological micro-milieu for specific plasma cells in anti-synthetase syndrome-associated myositis. Acta Neuropathologica, 2022, 144 (2), pp.353-372. ⟨10.1007/s00401-022-02438-z⟩. ⟨hal-03830925⟩
-
Lee Nguyen, Marie Bretagne, Jennifer Arrondeau, Noel Zahr, Stephane Ederhy, et al.. Reversal of immune-checkpoint inhibitor fulminant myocarditis using personalized-dose-adjusted abatacept and ruxolitinib: proof of concept. Journal for Immunotherapy of Cancer, 2022, 10 (4), pp.e004699. ⟨10.1136/jitc-2022-004699⟩. ⟨hal-03832478⟩
-
Lee Nguyen, Marie Bretagne, Jennifer Arrondeau, Noel Zahr, Stephane Ederhy, et al.. Reversal of immune-checkpoint inhibitor fulminant myocarditis using personalized-dose-adjusted abatacept and ruxolitinib: proof of concept. Journal for Immunotherapy of Cancer, 2022, 10 (4), pp.e004699. ⟨10.1136/jitc-2022-004699⟩. ⟨hal-04002766⟩
-
-
Stéphane Ederhy, Perrine Devos, Bruno Pinna, Elisa Funck-Brentano, Baptiste Abbar, et al.. 8 F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography imaging for the diagnosis of immune checkpoint inhibitors associated myocarditis. Archives of cardiovascular diseases, 2022, ⟨10.1016/j.acvd.2021.12.001⟩. ⟨hal-03561783⟩
-
Pierre Bay, Marc Pineton de Chambrun, Vincent Rothstein, Matthieu Mahevas, Nicolas de Prost, et al.. Plasma exchange are not associated with better outcome in MDA5 rapidly-progressive interstitial lung disease. French Intensive Care Society International Congress 2022, 2022, paris, France. pp.54, ⟨10.1186/s13613-022-01016-6⟩. ⟨hal-03831253⟩
Chiffres clés
123
Publications avec texte intégral
Open Access
53 %
Mots clés
Biomarker
Anti-interleukin-6
Lysosomal storage diseases
Autoantibody
Analyses multidimensionnelles
Animals
Autoantibodies
Muscle
Adverse drug reactions
Active
IMNM
Male
Deep immune profiling
Immunotherapy
Anti-Mi2
Anti-agalsidase antibodies
Immune checkpoint inhibitors
Case reports
Inclusion body myositis
Anémie hémolytique
Inborn errors of metabolism
Aldosterone
Aged
Bioelectrical impedance analysis
Abnormal movement
Adeno-associated vector
Machine learning
AAV vector
Mass cytometry
Adeno-associated virus
Cardio-oncology
Acute Kidney Injury/epidemiology/etiology
IBM
AAV humoral immunity
Adjudication
Autoimmunity
Systems biology
Antisynthétase
Assisted communication devices
Cytokines
Multidisciplinarity
Auto-antibodies
Idiopathic inflammatory myopathies
Biopsy
Outcome measures
Anti-MDA5 autoantibodies
Sphingosine-1-phosphate
Inflammation
Anti‐mitochondrial antibodies
AAV antibody
Middle Aged
Amyotrophy
Anti-synthetase syndrome
Prognosis
Antibodies
Biomarkers
Myopathy
Interstitial lung disease
Fabry disease
Female
Myocarditis
Arthritis
Skeletal muscle
Humans
Myositis
Anti-IgE IgG
Gene therapy
Agalsidase
Dermatomyositis
B-lymphocyte
Antibody responses
AAV
Acid-alpha-glucosidase
Dependovirus/genetics/immunology
B cell homeostasis
Anticorps spécifique des myosites
Aldostérone
Adeno-associated virus vector
DM
Adult
Auto-immunité
Auto‐antibodies
AAV vectors
Biomarqueurs
Autoimmune diseases
Myositis and muscle disease
Adolescence
Amyotrophic lateral sclerosis
Cancer
Antisynthetase syndrome
Anticorps anti-agalsidase
Pharmacology
Anti-drug antibodies
Inflammatory myopathy
COVID-19
Data integration
Polymyositis
Antiphospholipid syndrome
Antisynthetase
Interferon